NEWS NEWS
ConSyGen Hires Eric Strasser as New CFO And Promotes John D. Roskelley as Vice President of Business Development
TEMPE, Ariz., March 1 /PRNewswire/ -- ConSyGen (OTC Bulletin Board: CSGI - news) www.consygen.com, announced today that it has hired Eric Strasser as its Chief Financial Officer and has promoted John D. Roskelley to the position of Vice President of Business Development. Mr. Strasser started with ConSyGen on February 7th, 2000. Mr. Strasser brings a vast amount of leadership and financial knowledge to ConSyGen. Eric has served as a CPA and Senior Auditor for Peat Marwick and as a Vice President at Goldman Sachs.
Jason Genet, ConSyGen's Chief Operating Office stated, ``Eric brings superior money management skills to the company. Eric has worked hard to establish new financial relationships key to ConSyGen's strategic growth. In addition, we feel very comfortable with Eric's ability to keep our SEC financial filings in order and up to date.'
ConSyGen also announced today the promotion of John D. Roskelley to Vice President of Business Development. John has been with ConSyGen since May of 1999 as a consultant and Senior Business Development Analyst. He has been crucial in co-developing ConSyGen's new lines of business. John has spent the past 5 years in Program Development, Project Leadership and New Business Development. Prior to coming to ConSyGen, John was the Director of Client Engagements for Inacom in Phoenix, Arizona. John has also served in high-level technology consulting positions at Vanstar and MicroAge.
``We are very confident in John's abilities to lead ConSyGen's business development efforts,' said Genet. ``Since coming to ConSyGen, John has proven his ability to recognize and properly act upon industry and business trends relevant to our company.' Mr. Roskelley will be filling the position left vacant by Jason Genet's promotion to Chief Operating Officer. Mr. Genet concluded, ``I am very confident in John's abilities in developing new products and services which will lead to additional sources of revenue for ConSyGen.'
Lewis Burridge, ConSyGen's Chief Executive Officer stated, ``We are very pleased with management now in place. ConSyGen's empowered management team, Mr. Genet, Mr. Strasser and Mr. Roskelley along with myself, will lead ConSyGen with a great deal of integrity, professionalism, and dedication. This is truly a new company with a keen sense of direction and focus.'
Conference Call
ConSyGen will be sponsoring a conference call, to be hosted by Jason Genet, open to the media and all investors on Thursday, March 2nd at 4:05 PM EST. to discuss corporate and product developments. To participate, call (800) 720-5850 five minutes prior to the start of this call. The call will be recorded and available for playback for two weeks by calling the playback number: (800) 252-6030, access code 5762708.
ConSyGen's business is customer-driven, technology-influenced and service-oriented, coupled with world-class software development. In order to achieve the core company goals, various business units have the responsibility for developing cohesive missions, quantifiable objectives and comprehensive strategies. These business units include E-Commerce, Knowledge Mining, Internet Services, and Business Products.
Note to Editors: Caution Regarding Forward-Looking Statements: Statements contained in this release other than statements of historical fact may be deemed to be ``forward-looking statements.'
Forward-looking statements involve risks and uncertainties which may cause actual results to differ materially from those projected in such forward-looking statements. Factors which could affect results include the development of competing or superior technologies, market awareness and acceptance of ConSyGen's technology or products, overall market demand for conversion services, the company's ability to attract and retain qualified personnel and to protect its propriety information, and other risk factors set forth in the company's SEC filings.
CONTACT: Jason Genet of ConSyGen, Inc., 480-394-9100; or Tom Pikoulas of HKT Investor Relations, 480-446-8640, for ConSyGen, Inc.
SOURCE: ConSyGen, Inc. |
